Hot Biotechs (fka HOTBIO)

[BioSpecialist]

After BSDM now CLSN = 10 BAGGER

THE NEXT HYPE WILL START HERE ...

The technology is great and I believe game changing . I think you will be suitably impressed .ALWAYS DO YOUR OWN DD !!!!

Thermodox Phase III results coming .Thermodox has BLOCKBUSTER POTENTIAL (1-1,5 Billion Dollar Market Potential )

Market cap of 37 Mil$ is significantly undervalued for a BIG BLOCKBUSTER !!

Celsion (CLSN)

Market Cap : 37,4 Mil$
Cash : 5,68 Mil$ (+Celsion Corporation Secures $15 Million)
Price : 3,05 $

Shares Out : 12,27 M <<< LOW FLOAT


Insider Acitivity
http://finance.yahoo.com/q/it?s=CLSN+Insider+Transactions


From R&R Presentation:: WATCH

THERMODOX TIMELINE
http://www.wsw.com/webcast/rrshq18/clsn/2__Slide5.JPG

MARKET POTENTIAL
http://www.wsw.com/webcast/rrshq18/clsn/2__Slide7.JPG

Commercialization Plans
http://www.wsw.com/webcast/rrshq18/clsn/2__Slide8.JPG

THERMODOX
http://www.wsw.com/webcast/rrshq18/clsn/2__Slide12.JPG

UPCOMING MILESTONES
http://www.wsw.com/webcast/rrshq18/clsn/2__Slide22.JPG


"We continue to make substantial progress recruiting patients into our Phase III HEAT trial for ThermoDox(R). We continue to track well against our goal to complete enrollment by the end of this year," said Michael Tardugno, President and CEO of Celsion. "We have exceeded our goal of opening enrollment at 70 clinical trial sites with 74 enrolling world-wide. The Phase I/II DIGNITY trial of ThermoDox(R) in patients with recurrent chest wall breast cancer (RCW) also continues to advance. We are currently enrolling patients in the 50mg/m2 dosing cohort, which will be used to determine our therapeutic dose."